The CDC's emergency operations center is watching the outbreak around the clock.
Patient advocates say some insurance companies are making HIV and AIDS drugs unaffordable in plans issued through the Affordable Care Act by shifting much of the cost to customers. While the issue applies broadly to all patients with chronic illnesses that require expensive medication, HIV and AIDS advocates say they were the first to file a formal complaint with the government about pricing.
The Medicines Company today announced that the FDA has approved ORBACTIV™ (oritavancin) for injection for the treatment of adults with acute bacterial skin and skin structure infections (ABSSSIs) caused by susceptible designated Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA).
Mallinckrodt today announced that its subsidiary, Cadence Pharmaceuticals, Inc., has entered into settlement and license agreements with Fresenius Kabi USA, LLC, resolving pending patent litigation involving OFIRMEV ® (acetaminophen) injection.
New Takeda Pharmaceutical Company President Christophe Weber said recently that Japan's biggest drugmaker will continue efforts to expand its business abroad through acquisitions and will outline a new strategy by the end of the year.
As a deadly Ebola outbreak continues in West Africa, health officials are working to calm fears about how the virus spreads, while encouraging those with symptoms to get medical care. Typically, outbreaks of the disease have been in other parts of the continent, not in West Africa.
It's long been known that faulty BRCA genes greatly raise the risk for breast cancer. Now scientists say a more recently identified, less common gene can do the same.
The Food and Drug Administration is warning tattoo parlors, their customers and those buying at-home tattoo kits that not all tattoo ink is safe. Last month, California company White and Blue Lion Inc. recalled inks in in-home tattoo kits after testing confirmed bacterial contamination in unopened bottles.
Veterans are expected to have an easier time getting government-paid health care from local doctors under a bill that President Barack Obama is set to sign into law Thursday.
Mylan reported profit that declined by 30 percent in its second quarter, and missed analysts' expectations. The Canonsburg, Pennsylvania-based company said net income fell to $125.2 million, or 32 cents per share, from $177.7 million, or 46 cents per share.
Pfizer will pay $35 million to resolve allegations by 42 states that its subsidiary, Wyeth Pharmaceuticals, illegally marketed an organ transplant drug for unapproved uses. The states' attorneys general said Wednesday that Wyeth, which Pfizer bought in 2009, trained sales representatives to prescribe Rapamune for uses other than preventing rejection of transplanted kidneys.
Introducing the TP-3010-19AIO and TP-3010-22AIO all-in-one touch-screen, fanless computers with core i3/i5/i7 processors.
The MX Immersion Circulator enables quality control and R&D charged with testing tablet disintegration time to maintain the testing media at the precise temperature required.
New research from London shows taking aspirin can significantly reduce the risk of digestive cancers.
Health officials are unsure whether the drug is working but friends of the infected are hopeful.